Home / Universität / Universitätskliniken / Universitätsklinik für Neurologie / Publikationen
Universitätsklinik für Neurologie

Publikationen

  1. 2020

    • Zeitschriftenartikel

      • Diem, L., Daponte, A., Findling, O., Miclea, A., Briner, M., Salmen, A., Gold, R., Kilidireas, C., Chan, A., Evangelopoulos, M.Elftheria & Hoepner, R., 2020. Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study. Neurology(R) neuroimmunology & neuroinflammation, 7(2).

      • Findling, O., Hauer, L., Pezawas, T., Rommer, P.S., Struhal, W. & Sellner, J., 2020. Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies. Journal of clinical medicine, 9(2).

  2. 2019

    • Zeitschriftenartikel

      • Damulina, A., Pirpamer, L., Seiler, S., Benke, T., Dal-Bianco, P., Ransmayr, G., Struhal, W., Hofer, E., Langkammer, C., Duering, M., Fazekas, F. & Schmidt, R., 2019. White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study. Journal of Alzheimer's disease : JAD, 68, S.789-796.

      • Haider, L., Chan, W.-S.Evelyn, Olbert, E., Mangesius, S., Dal-Bianco, A., Leutmezer, F., Prayer, D. & Thurnher, M., 2019. Cranial Nerve Enhancement in Multiple Sclerosis Is Associated With Younger Age at Onset and More Severe Disease. Frontiers in neurology, 10, S.1085.

      • Jordan, J., Fanciulli, A., Tank, J., Calandra-Buonaura, G., Cheshire, W.P., Cortelli, P., Eschlboeck, S., Grassi, G., Hilz, M.J., Kaufmann, H., Lahrmann, H., Mancia, G., Mayer, G., Norcliffe-Kaufmann, L., Le Traon, A.Pavy-, Raj, S.R., Robertson, D., Rocha, I., Reuter, H., Struhal, W., Thijs, R.D., Tsioufis, K.P., J. van Dijk, G., Wenning, G.K. & Biaggioni, I., 2019. Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. Journal of hypertension, 37, S.1541-1546.

      • Krenn, M., Milenkovic, I., Eckstein, G., Zimprich, F., Meitinger, T., Foki, T. & Wagner, M., 2019. Adult-onset variant ataxia-telangiectasia diagnosed by exome and cDNA sequencing. Neurology. Genetics, 5, S.e346.

      • Neuhauser, M., Roetzer, T., Oberndorfer, S., Kitzwögerer, M., Payer, F., Unterluggauer, J.J., Haybaeck, J., Stockhammer, G., Iglseder, S., Moser, P., Thomé, C., Stultschnig, M., Wuertz, F., Brandner-Kokalj, T., Weis, S., Bandke, D., Pichler, J., Hutterer, M., Krenosz, K.J., Boehm, A., Mayrbaeurl, B., Hager-Seifert, A., Kaufmann, H., Dumser, M., Reiner-Concin, A., Hoenigschnabl, S., Kleindienst, W., Hoffermann, M., Dieckmann, K., Kiesel, B., Widhalm, G., Marosi, C., Jaeger, U., Hainfellner, A., Hackl, M., Hainfellner, J.A., Preusser, M. & Woehrer, A., 2019. Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study. Acta oncologica, 58, S.967-976.

      • Oberndorfer, S. & Hutterer, M., 2019. Palliative care in glioma management. Current opinion in oncology, 31, S.548-553.

      • Stadlbauer, A., Buchfelder, M., Dorfler, A. & Oberndorfer, S., 2019. Advanced MRI in neuro-oncology: can we proceed without inclusion of energy metabolism?. Oncotarget, 10, S.3994-3995.

      • Stadlbauer, A., Eyupoglu, I., Buchfelder, M., Dorfler, A., Zimmermann, M., Heinz, G. & Oberndorfer, S., 2019. Vascular architecture mapping for early detection of glioblastoma recurrence. Neurosurgical focus, 47(6), S.E14.

      • Stadlbauer, A., Oberndorfer, S., Zimmermann, M., Renner, B., Buchfelder, M., Heinz, G., Doerfler, A., Kleindienst, A. & Roessler, K., 2019. Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, S.271678X19827885.

      • Stadlbauer, A., Roessler, K., Zimmermann, M., Buchfelder, M., Kleindienst, A., Doerfler, A., Heinz, G. & Oberndorfer, S., 2019. Predicting Glioblastoma Response to Bevacizumab Through MRI Biomarkers of the Tumor Microenvironment. Molecular imaging and biology, 21(4), S.747-757.

      • Stadlbauer, A., Roessler, K., Zimmermann, M., Buchfelder, M., Kleindienst, A., Doerfler, A., Heinz, G. & Oberndorfer, S., 2019. Predicting Glioblastoma Response to Bevacizumab Through MRI Biomarkers of the Tumor Microenvironment. Molecular imaging and biology, 21, S.747-757.

      • Topakian, R., Zimprich, F., Iglseder, S., Embacher, N., Guger, M., Stieglbauer, K., Langenscheidt, D., Rath, J., Quasthoff, S., Simschitz, P., Wanschitz, J., Windisch, D., Muller, P., Oel, D., Schustereder, G., Einsiedler, S., Eggers, C. & Löscher, W., 2019. High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria. Journal of neurology, 266, S.699-706.

  3. 2018

    • Zeitschriftenartikel

      • Brainin, M., Feigin, V., Martins, S., Matz, K., Roy, J., Sandercock, P., Teuschl, Y., Tuomilehto, J. & Wiseman, A., 2018. Cut stroke in half: Polypill for primary prevention in stroke. International Journal of Stroke, 13, S.633-647.

      • Buchroithner, J., Erhart, F., Pichler, J., Widhalm, G., Preusser, M., Stockhammer, G., Nowosielski, M., Iglseder, S., Freyschlag, C.F., Oberndorfer, S., Bordihn, K., von Campe, G., Hoffermann, M., Ruckser, R., Rossler, K., Spiegl-Kreinecker, S., Fischer, M.B., Czech, T., Visus, C., Krumpl, G., Felzmann, T. & Marosi, C., 2018. Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial. Cancers, 10.

      • Christensen, M. & Trapl, M., 2018. Development of a modified swallowing screening tool to manage post-extubation dysphagia. Nursing in Critical Care, 23, S.102-107.

      • Fanciulli, A., Jordan, J., Biaggioni, I., Calandra-Buonaura, G., Cheshire, W.P., Cortelli, P., Eschlboeck, S., Grassi, G., Hilz, M.J., Kaufmann, H., Lahrmann, H., Mancia, G., Mayer, G., Norcliffe-Kaufmann, L., Le Traon, A.Pavy-, Raj, S.R., Robertson, D., Rocha, I., Struhal, W., Thijs, R., Tsioufis, K.P., J van Dijk, G. & Wenning, G.K., 2018. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS). Clinical Autonomic Research, 28, S.355-362.

      • Hart, R.G., Sharma, M., Mundl, H., Kasner, S.E., Bangdiwala, S.I., Berkowitz, S.D., Swaminathan, B., Lavados, P., Wang, Y., Wang, Y., Davalos, A., Shamalov, N., Mikulik, R., Cunha, L., Lindgren, A., Arauz, A., Lang, W., Czlonkowska, A., Eckstein, J., Gagliardi, R.J., Amarenco, P., Ameriso, S.F., Tatlisumak, T., Veltkamp, R., Hankey, G.J., Toni, D., Bereczki, D., Uchiyama, S., Ntaios, G., Yoon, B.W., Brouns, R., Endres, M., Muir, K.W., Bornstein, N., Ozturk, S., O'Donnell, M.J., Basson, M.M.De Vrie, Pare, G., Pater, C., Kirsch, B., Sheridan, P., Peters, G., Weitz, J.I., Peacock, W.F., Shoamanesh, A., Benavente, O.R., Joyner, C., Themeles, E., Connolly, S.J. & Oberndorfer, S., 2018. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. The New England Journal of Medicine, 378, S.2191-2201.

      • Hayes, J., Yu, Y., Jalbert, L.E., Mazor, T., Jones, L.E., Wood, M.D., Walsh, K.M., Bengtsson, H., Hong, C., Oberndorfer, S., Roetzer, T., Smirnov, I.V., Clarke, J.L., Aghi, M.K., Chang, S.M., Nelson, S.J., Woehrer, A., Phillips, J.J., Solomon, D.A. & Costello, J.F., 2018. Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Neuro-Oncology, 20, S.632-641.

      • Kasner, S.E., Swaminathan, B., Lavados, P., Sharma, M., Muir, K., Veltkamp, R., Ameriso, S.F., Endres, M., Lutsep, H., Messe, S.R., J Spence, D., Nedeltechev, K., Perera, K., Santo, G., Olavarria, V., Lindgren, A., Bangdiwala, S., Shoamanesh, A., Berkowitz, S.D., Mundl, H., Connolly, S.J., Hart, R.G. & Oberndorfer, S., 2018. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurology, 17, S.1053-1060.

      • Klughammer, J., Kiesel, B., Roetzer, T., Fortelny, N., Nemc, A., Nenning, K.-H., Furtner, J., Sheffield, N.C., Datlinger, P., Peter, N., Nowosielski, M., Augustin, M., Mischkulnig, M., Ströbel, T., Alpar, D., Ergüner, B., Senekowitsch, M., Moser, P., Freyschlag, C.F., Kerschbaumer, J., Thomé, C., Grams, A.E., Stockhammer, G., Kitzwögerer, M., Oberndorfer, S., Marhold, F., Weis, S., Trenkler, J., Buchroithner, J., Pichler, J., Haybaeck, J., Krassnig, S., Ali, K.Mahdy, von Campe, G., Payer, F., Sherif, C., Preiser, J., Hauser, T., Winkler, P.A., Kleindienst, W., Würtz, F., Brandner-Kokalj, T., Stultschnig, M., Schweiger, S., Dieckmann, K., Preusser, M., Langs, G., Baumann, B., Knosp, E., Widhalm, G., Marosi, C., Hainfellner, J.A., Woehrer, A. & Bock, C., 2018. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nature Medicine, 24, S.1611-1624.

      • Loscher, W.N., Oberreiter, E.-M., Erdler, M., Quasthoff, S., Culea, V., Berek, K., Embacher, N., Grinzinger, S., Hess, I., Hoger, F.Stefan, Horlings, C.G.C., Huemer, M., Jecel, J., Kleindienst, W., Laich, E., Muller, P., Oel, D., Ortl, W., Lenzenweger, E., Rath, J., Stadler, K., Stieglbauer, K., Thaler-Wolf, C., Wanschitz, J., Zimprich, F., Cetin, H. & Topakian, R., 2018. Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment. Journal of Neurology, 265, S.2834-2840.

      • Mayer, L., Ferrari, J., Krebs, S., Boehme, C., Toell, T., Matosevic, B., Tinchon, A., Brainin, M., Gattringer, T., Sommer, P., Thun, P., Willeit, J., Lang, W., Kiechl, S., Knoflach, M. & Unit, C.Austrian S., 2018. ABCD3-I score and the risk of early or 3-month stroke recurrence in tissue- and time-based definitions of TIA and minor stroke. Journal of Neurology, 265, S.530-534.

      • Pieh, C., Jank, R., Waiß, C., Pfeifer, C., Probst, T., Lahmann, C. & Oberndorfer, S., 2018. Night-shift work increases cold pain perception. Sleep Medicine, 45, S.74-79.

      • Roetzer, T., Kitzwögerer, M., Heinz, G., Oberndorfer, S., Marhold, F., Hainfellner, J.A. & Woehrer, A., 2018. Spatiotemporal evolution of a low-grade glioma with divergent oligodendroglial and astrocytic lineages. Clinical Neuropathology, 37, S.82-84.

      • Stadlbauer, A., Mouridsen, K., Doerfler, A., Hansen, M.Bo, Oberndorfer, S., Zimmermann, M., Buchfelder, M., Heinz, G. & Roessler, K., 2018. Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 38(3), S.422-432.

      • Stadlbauer, A., Mouridsen, K., Doerfler, A., M. Hansen, B., Oberndorfer, S., Zimmermann, M., Buchfelder, M., Heinz, G. & Roessler, K., 2018. Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia. Journal of Cerebral Blood Flow and Metabolism, 38, S.422-432.

      • Stadlbauer, A., Roessler, K., Zimmermann, M., Buchfelder, M., Kleindienst, A., Doerfler, A., Heinz, G. & Oberndorfer, S., 2018. Predicting Glioblastoma Response to Bevacizumab Through MRI Biomarkers of the Tumor Microenvironment. Molecular Imaging and Biology.

      • Stadlbauer, A., Zimmermann, M., Doerfler, A., Oberndorfer, S., Buchfelder, M., Coras, R., Kitzwögerer, M. & Roessler, K., 2018. Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma. Neuro-oncology, 20(11), S.1536-1546.

      • Stadlbauer, A., Zimmermann, M., Doerfler, A., Oberndorfer, S., Buchfelder, M., Coras, R., Kitzwögerer, M. & Roessler, K., 2018. Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma. Neuro-Oncology, 20, S.1536-1546.

      • Teuschl, Y., Ihle-Hansen, H., Matz, K., Dachenhausen, A., Ratajczak, P., Tuomilehto, J., Ursin, M.H., Hagberg, G., Thommessen, B., Oksengard, A.R. & Brainin, M., 2018. Multidomain intervention for the prevention of cognitive decline after stroke - a pooled patient-level data analysis. European Journal of Neurology, 25, S.1182-1188.

      • Teuschl, Y., Trapl, M., Ratajczak, P., Matz, K., Dachenhausen, A. & Brainin, M., 2018. Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. PLoS One, 13, S.e0192142.

      • Thomalla, G., Simonsen, C.Z., Boutitie, F., Andersen, G., Berthezene, Y., Cheng, B., Cheripelli, B., Cho, T.H., Fazekas, F., Fiehler, J., Ford, I., Galinovic, I., Gellissen, S., Golsari, A., Gregori, J., Gunther, M., Guibernau, J., Hausler, K.G., Hennerici, M., Kemmling, A., Marstrand, J., Modrau, B., Neeb, L., N. de la Ossa, P., Puig, J., Ringleb, P., Roy, P., Scheel, E., Schonewille, W., Serena, J., Sunaert, S., Villringer, K., Wouters, A., Thijs, V., Ebinger, M., Endres, M., Fiebach, J.B., Lemmens, R., Muir, K.W., Nighoghossian, N., Pedraza, S. & Gerloff, C., 2018. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset S. Oberndorfer, hrsg. The New England Journal of Medicine, 379, S.611-622.

    • andere wissenschaftliche Beiträge

      • Oberndorfer, S. & Hainfellner, J., 2018. ABTR-SANOnet. Neurologisch, 1, S.162-63.

      • Oberndorfer, S., 2018. Auswirkungen der überarbeiteten WHO Klassifikation 2016 auf die Therapie von Gliomen. Neurologisch, 2, S.48-49.

      • Oberndorfer, S., 2018. Cannabinoide in der Neuroonkologie. Neurologisch, S.82-83.

      • Oberndorfer, S., 2018. Management Tumor assoziierter Epilepsie. Krebshilfe , 5, S.14-16.

      • Oberndorfer, S., 2018. Multimodale Diagnostik bei Glioblastomen. Jatros Neurologie und Psychiatrie , S.16-17.

      • Oberndorfer, S., 2018. Palliativmedizin in der Neuroonkologie. Neurologisch, 2, S.38-40.

  4. 2017

    • Zeitschriftenartikel

      • Pace, A., Dirven, L., Koekkoek, J.A.F., Golla, H., Fleming, J., Ruda, R., Marosi, C., Le Rhun, E., Grant, R., Oliver, K., Oberg, I., Bulbeck, H.J., Rooney, A.G., Henriksson, R., H. Pasman, R.W., Oberndorfer, S., Weller, M., Taphoorn, M.J.B. & task, forceEuropean A., 2017. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. The Lancet. Oncology, 18(6), S.e330-e340.

      • Pace, A., Dirven, L., Koekkoek, J.A.F., Golla, H., Fleming, J., Ruda, R., Marosi, C., Le Rhun, E., Grant, R., Oliver, K., Oberg, I., Bulbeck, H.J., Rooney, A.G., Henriksson, R., Pasman, H.R.W., Oberndorfer, S., Weller, M. & Taphoorn, M.J.B., 2017. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. The Lancet Oncology, 18, S.e330-e340.

      • Seifert-Held, T., Langner-Wegscheider, B.J., Komposch, M., Simschitz, P., Franta, C., Teuchner, B., Offenbacher, H., Otto, F., Sellner, J., Rauschka, H. & Fazekas, F., 2017. Susac's syndrome: clinical course and epidemiology in a Central European population. International Journal of Neuroscience, 127, S.776-780.

      • Stadlbauer, A., Zimmermann, M., Heinz, G., Oberndorfer, S., Doerfler, A., Buchfelder, M. & Rossler, K., 2017. Magnetic resonance imaging biomarkers for clinical routine assessment of microvascular architecture in glioma. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 37(2), S.632-643.

      • Stadlbauer, A., Zimmermann, M., Heinz, G., Oberndorfer, S., Doerfler, A., Buchfelder, M. & Rossler, K., 2017. Magnetic resonance imaging biomarkers for clinical routine assessment of microvascular architecture in glioma. Journal of Cerebral Blood Flow and Metabolism, 37, S.632-643.

      • Stadlbauer, A., Zimmermann, M., Kitzwögerer, M., Oberndorfer, S., Rossler, K., Dorfler, A., Buchfelder, M. & Heinz, G., 2017. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas. Radiology, 283, S.799-809.

      • Stadlbauer, A., Zimmermann, M., Oberndorfer, S., Doerfler, A., Buchfelder, M., Heinz, G. & Roessler, K., 2017. Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy. Scientific reports, 7(1), S.8508.

      • Stadlbauer, A., Zimmermann, M., Oberndorfer, S., Doerfler, A., Buchfelder, M., Heinz, G. & Roessler, K., 2017. Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy. Scientific Reports, 7, S.8508.

      • Teuschl, Y., Matz, K., Firlinger, B., Dachenhausen, A., Tuomilehto, J. & Brainin, M., 2017. Preventive effects of multiple domain interventions on lifestyle and risk factor changes in stroke survivors: Evidence from a two-year randomized trial. International Journal of Stroke, 12, S.976-984.

      • Waiß, C., Kindler, W., Strobele, B., Aspock, C. & Oberndorfer, S., 2017. CXCL-13 as a biomarker in the diagnostics of neuroborreliosis - CXCL-13 als Biomarker in der Diagnostik der Neuroborreliose. Nervenarzt, 88, S.635-641.

  5. 2016

    • Zeitschriftenartikel

      • Kindler, W., Wolf, H., Thier, K. & Oberndorfer, S., 2016. Peripheral facial palsy as an initial symptom of Lyme neuroborreliosis in an Austrian endemic area. Wiener klinische Wochenschrift, 128, S.837-840.

      • Knoflach, M., Lang, W., Seyfang, L., Fertl, E., Oberndorfer, S., Daniel, G., Seifert-Held, T., Brainin, M., Krebs, S., Matosevic, B., Toll, T., Kiechl, S., Willeit, J. & Ferrari, J., 2016. Predictive value of ABCD2 and ABCD3-I scores in TIA and minor stroke in the stroke unit setting. Neurology, 87, S.861-9.

      • Matz, K., Seyfang, L., Dachenhausen, A., Teuschl, Y., Tuomilehto, J. & Brainin, M., 2016. Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. BMC Neurology, 16, S.107.

      • Matz, K., Seyfang, L., Dachenhausen, A., Teuschl, Y., Tuomilehto, J., Brainin, M. & Collaborators, M.D. for the, 2016. Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. BMC neurology, 16, S.107.

      • Oberndorfer, S. & Lorenzl, S., 2016. Pro & Contra: Soll man ein Glioblastomrezidiv (aggressiv) behandeln?. neurologisch - Fachmagazin für Neurologie, 02/2016, S.22-24.

      • Serles, W., Gattringer, T., Mutzenbach, S., Seyfang, L., Trenkler, J., Killer-Oberpfalzer, M., Deutschmann, H., Niederkorn, K., Wolf, F., Gruber, A., Hausegger, K., Weber, J., Thurnher, S., Gizewski, E., Willeit, J., Karaic, R., Fertl, E., Nasel, C., Brainin, M., Erian, J., Oberndorfer, S., Karnel, F., Grisold, W., Auff, E., Fazekas, F., Haring, H.P. & Lang, W., 2016. Endovascular stroke therapy in Austria: a nationwide 1-year experience. European Journal of Neurology, 23, S.906-11.

      • Thier, K., Calabek, B., Tinchon, A., Grisold, W. & Oberndorfer, S., 2016. The Last 10 Days of Patients With Glioblastoma: Assessment of Clinical Signs and Symptoms as well as Treatment. American Journal of Hospice and Palliative Care, 33, S.985-988.

      • Wolf, H., Neuhauser, C., Franta, C., Hauer, D., Ungersboeck, K. & Oberndorfer, S., 2016. Komplikationen bei intrathekaler Baclofentherapie. Journal für Neurologie, Neurochirurgie und Psychiatrie, 17, S.13-15.

  6. 2015

    • Zeitschriftenartikel

      • Brainin, M., Matz, K., Nemec, M., Teuschl, Y., Dachenhausen, A., Asenbaum-Nan, S., Bancher, C., Kepplinger, B., Oberndorfer, S., Pinter, M., Schnider, P., Tuomilehto, J. & Group, A.Study, 2015. Prevention of poststroke cognitive decline: ASPIS--a multicenter, randomized, observer-blind, parallel group clinical trial to evaluate multiple lifestyle interventions--study design and baseline characteristics. International Journal of Stroke, 10, S.627-35.

      • Kunzmann, J., Wolf, H. & Oberndorfer, S., 2015. Generalised reversible encephalopathy syndrome: a variant of posterior reversible encephalopathy syndrome (PRES). BMJ Case Reports, 2015.

      • Matz, K., Teuschl, Y., Firlinger, B., Dachenhausen, A., Keindl, M., Seyfang, L., Tuomilehto, J., Brainin, M., Group, A.Study, Schnider, P., Bancher, C., Pinter, M., Kepplinger, B., Asenbaum-Nan, S., Oberndorfer, S. & Heiss, W.-D., 2015. Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial. Stroke, 46, S.2874-80.

      • Ressl, N. & Oberndorfer, S., 2015. Multiple calcified brain metastases in a man with invasive ductal breast cancer. BMJ Case Reports, 2015.

      • Tinchon, A., Oberndorfer, S., Marosi, C., Gleiss, A., Geroldinger, A., Sax, C., Sherif, C., Moser, W. & Grisold, W., 2015. Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study. Journal of Neurology, 262, S.179-86.

  7. 2014

    • Zeitschriftenartikel

      • Buchroithner, J., Pichler, J., Marosi, C., Widhalm, G., Seiz-Rosenhagen, M., Novosielski, M., Oberndorfer, S., Ruckser, R., Rossler, K., Azizi, A., von Campe, G., Bordihn, K. & Felzmann, T., 2014. Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy. International Journal of Clinical Pharmacology and Therapeutics, 52, S.76-7.

      • Gattringer, T., Niederkorn, K., Seyfang, L., Seifert-Held, T., Simmet, N., Ferrari, J., Lang, W., Brainin, M., Willeit, J., Fazekas, F. & Enzinger, C., 2014. Myocardial infarction as a complication in acute stroke: results from the austrian stroke unit registry. Cerebrovascular Diseases, 37, S.147-52.

      • Hutterer, M., Nowosielski, M., Haybaeck, J., Embacher, S., Stockhammer, F., Gotwald, T., Holzner, B., Capper, D., Preusser, M., Marosi, C., Oberndorfer, S., Moik, M., Buchroithner, J., Seiz, M., Tuettenberg, J., Herrlinger, U., Wick, A., Vajkoczy, P. & Stockhammer, G., 2014. A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro-Oncology, 16, S.92-102.

      • Koekkoek, J.A., Dirven, L., Reijneveld, J.C., Sizoo, E.M., Pasman, H.R., Postma, T.J., Deliens, L., Grant, R., McNamara, S., Grisold, W., Medicus, E., Stockhammer, G., Oberndorfer, S., Flechl, B., Marosi, C., Taphoorn, M.J. & Heimans, J.J., 2014. End of life care in high-grade glioma patients in three European countries: a comparative study. Journal of Neuro-Oncology, 120, S.303-10.

      • Moser, W., Marhold, F., Ungersboeck, K. & Oberndorfer, S., 2014. Subacute spinal cord compression due to an intramedullar spinal teratoma in a 53-year old female patient: a case report. European Association of NeuroOncology Magazine, 4, S.1-3.

      • Moser, W., Thier, K., Hafner, C., Trautinger, F., Ungersboeck, K., Sedivy, R. & Oberndorfer, S., 2014. Primary Intrathecal Melanoma Arising from Meningeal Melanocytosis: A Case Report. Neuro-Oncology, 16, S.ii54.

      • Oberndorfer, S., Ungersboeck, K., Moser, W., Riedlberger, U., Marhold, F., Heinz, G., Sedivy, R., Brustbauer, R., Kopetzky, G., Vyhnalik, M. & Balcke, P., 2014. Interdisziplinäre neuroonkologische Betreuung eines Patienten mit sekundärem Gliobalstom. Tumorboard, 3, S.13-16.

      • Reiter, M., Teuschl, Y., Matz, K., Seyfang, L., Brainin, M. & Registry, C.Austrian S., 2014. Diabetes and thrombolysis for acute stroke: a clear benefit for diabetics. European Journal of Neurology, 21, S.5-10.

      • Woehrer, A., Hackl, M., Waldhor, T., Weis, S., Pichler, J., Olschowski, A., Buchroithner, J., Maier, H., Stockhammer, G., Thome, C., Haybaeck, J., Payer, F., von Campe, G., Kiefer, A., Wurtz, F., Vince, G.H., Sedivy, R., Oberndorfer, S., Marhold, F., Bordihn, K., Stiglbauer, W., Gruber-Mosenbacher, U., Bauer, R., Feichtinger, J., Reiner-Concin, A., Grisold, W., Marosi, C., Preusser, M., Dieckmann, K., Slavc, I., Gatterbauer, B., Widhalm, G., Haberler, C. & Hainfellner, J.A., 2014. Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry. British Journal of Cancer, 110, S.286-96.

Events

  1. 27 Feb

    Neurophysiologie-Symposium: Ionenkanäle in Nervenzellen und damit verbundene Krankheiten

    27. Februar 2020, 15:30 - 18:30
    Karl Landsteiner Privatuniversität für Gesundheitswissenschaften, Trakt Y, EG, Auditorium
  2. 05 Mär

    Symposion Dürnstein 2020

    05. März 2020, 18:00 - 07. März 2020, 16:00
    Stift Dürnstein, Prälatensaal, 3601 Dürnstein
  3. 09 Mär

    Teddybär Krankenhaus

    09. März 2020, 09:00 - 10. März 2020, 16:00
    Universitätsklinikum Krems, Mitterweg 10, 3500 Krems